Berkeley, CA, United States of America

Xiaohui A Zhou


Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 149(Granted Patents)


Company Filing History:


Years Active: 2002-2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Xiaohui A. Zhou in Glycogen Synthase Kinase 3 Research

Introduction

Xiaohui A. Zhou, an accomplished inventor based in Berkeley, CA, has made significant strides in the field of biochemistry. With a total of four patents to her name, she has focused her research on developing novel compounds and methodologies to inhibit glycogen synthase kinase 3 (GSK3), a critical enzyme implicated in various medical disorders.

Latest Patents

Among her most recent patents are innovative compounds designed to inhibit the activity of GSK3. One such patent introduces new pyrimidine or pyridine-based compounds, which have shown promise in treating disorders mediated by GSK3 activity. These include debilitating conditions such as diabetes, Alzheimer's disease, and neurodegenerative disorders, as well as obesity, essential hypertension, and various cancers. Another noteworthy patent involves bicyclic inhibitors of GSK3, which again emphasizes the potential for these compounds to be utilized in combination with other pharmacologically active agents for enhanced therapeutic effects.

Career Highlights

Xiaohui A. Zhou is affiliated with Chiron Corporation, a well-respected organization contributing to biomedical advancements. Her work at the company has positioned her as a key player in the research community, where her innovations are paving the way for new treatment options for serious health conditions.

Collaborations

Throughout her career, Zhou has collaborated with esteemed colleagues such as John M. Nuss and Dane A. Goff. These partnerships have not only enhanced her research capabilities but have also fostered a collaborative environment that drives innovation in the field.

Conclusion

Xiaohui A. Zhou's contributions to the field of glycogen synthase kinase research exemplify her commitment to scientific advancement and improving public health. With her innovative patents and collaborative spirit, she continues to influence the landscape of biomedical research, thereby promising a brighter future for patients suffering from various GSK3-mediated disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…